ArticleFrontiers in endocrinology2026
The association between estimated glucose disposal rate and self-reported diabetic retinopathy: evidence from two independent cohorts and machine learning.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Insulin resistance plays a key role in the pathogenesis of diabetic retinopathy (DR). Although established insulin resistance markers have been shown to predict a variety of complications, the association between the estimated glucose disposal rate (eGDR) and prevalence of DR remains incompletely characterized. This study aims to examine the relationship between eGDR and DR prevalence. Methods: This cross-sectional study analyzed complete participant data (N = 1, 536) from the 2007-2018 National Health and Nutrition Examination Survey (NHANES) for all relevant information. The relationship between the insulin resistance index and self-reported DR prevalence was evaluated by using multivariate logistic regression and a restricted cubic spline (RCS) model. Subgroup analysis was conducted to assess heterogeneity across groups, and two sensitivity analyses were performed to assess the robustness of the results. In machine learning, the Boruta algorithm is applied for feature selection. The selected features are subsequently utilized by XGBoost and random forest models for DR prevalence estimation. Use the Shapley additive explanations (SHAP) value to explain the independent contribution of eGDR. In the clinical cohort, we recruited patients who visited the Second Affiliated Hospital of Anhui Medical University from September 1, 2025, to December 30, 2025. A total of 297 participants who met the inclusion criteria were finally enrolled. Multivariable logistic regression and RCS curves were used to validate the findings from the NHANES analysis. Results: In the fully adjusted model, eGDR and self-reported DR prevalence show a significant negative linear correlation (OR = 0.79, 95% CI: 0.67-0.93, P = 0.0049). Subgroup and sensitivity analyses confirm the stability of this negative association. The Boruta algorithm identifies eGDR as a robust and important feature. Both the XGBoost (AUC = 0.773) and random forest (AUC = 0.764) models show moderate predictive performance, and eGDR has high variable importance. SHAP analysis indicates that eGDR, together with body mass index and income poverty, is a key determinant of self-reported DR prevalence. The results of the clinical cohort are like NHANES. Conclusion: This cross-sectional study suggested that lower eGDR is associated with a higher prevalence of self-reported DR. Accordingly, eGDR may serve as a potential marker for risk stratification rather than a causal or preventive factor. Prospective longitudinal research is necessary to confirm these findings and to explore whether a causal relationship exists.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.